Compass Financial Advisors LLC Abb Vie Inc. Transaction History

Compass Financial Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $867 - $999	6 Added 0.1%	5,831 $929,000
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $10,511 - $12,606	-76 Reduced 1.29%	5,825 $941,000
Q3 2022 Nov 09, 2022	SELL	$134.21 - $153.93 $87,370 - $100,208	-651 Reduced 9.94%	5,901 $792,000
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $9,633 - $12,247	70 Added 1.08%	6,552 $1 Million
Q1 2022 May 05, 2022	BUY	$131.98 - $163.75 $93,045 - $115,443	705 Added 12.2%	6,482 $1.05 Million
Q4 2021 Feb 24, 2022	BUY	$107.43 - $135.93 $620,623 - $785,267	5,777 New	5,777 $782,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Compass Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Compass Financial Advisors LLC with notifications on news.